Proteomic Analysis Reveals Upregulation of ACE2 (Angiotensin-Converting Enzyme 2), the Putative SARS-CoV-2 Receptor in Pressure-but Not Volume-Overloaded Human Hearts
Authors:
- Johannes StegbauerJSJohannes Stegbauer
- Milena KrausMKMilena Kraus
- Sarah NordmeyerSNSarah Nordmeyer
- Marieluise KirchnerMKMarieluise Kirchner
- Matthias ZiehmMZMatthias Ziehm
- Henrik DommischHDHenrik Dommisch
- Sebastian KelleSKSebastian Kelle
- Marcus KelmMKMarcus Kelm
- Istvan BaczkoIBIstvan Baczko
- Ulf LandmesserULUlf Landmesser
- Carsten TschöpeCTCarsten Tschöpe
- Christoph KnosallaCKChristoph Knosalla
- 1 December 2020
- journal article
- letter
- Published by Wolters Kluwer Health in Hypertension
- Vol. 76 (6) , E41-E43
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy CasesJAMA Cardiology, 2020
- Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin SystemCirculation Research, 2020
- Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human heartsEuropean Heart Journal, 2020
- Deletion of Angiotensin-Converting Enzyme 2 Accelerates Pressure Overload-Induced Cardiac Dysfunction by Increasing Local Angiotensin IIHypertension, 2006